BRAF V600 inhibitor discontinuation after complete response in advanced melanoma: a retrospective analysis of 16 patients.
C VanhaeckeF DeilhesJ ChanalE Regnier-RosencherF BoitierS BoulinguezM-F AvrilS GuéganN DupinS AractingiNicolas MeyerN KramkimelPublished in: The British journal of dermatology (2017)